ASAS Centennial paper: a century of pioneers and progress in meat science in the United States leads to new frontiers.

Discoveries, understanding, and innovations in meat science during the last century have led to revolutionary changes in meat and poultry production, processing, marketing, and consumption. American Society of Animal Science members have made key contributions in most, if not all, categories of advancement. The first US university meat science program was begun in Minnesota in 1905. Use of mechanical refrigeration in the meatpacking industry, improved transportation and packaging, and home refrigeration provided more flexibility, variety, and consistency in meat and meat products in the early 1900s. Cooperative meat research was begun by 27 universities in 1925, with a focus on the observational characterization of carcass traits and composition, meat quality attributes, and causes of the wide variation in these variables. Scientific study of genetic, nutritional, and environmental influences on the growth, physiology, and postmortem biochemistry of muscle often used muscle-comparative investigations. Rigor mortis, cold shortening and thaw rigor, postmortem muscle metabolism, postmortem tenderization and tenderness variation, and postmortem myoglobin and lipid oxidation were studied vigorously in the 1960s and beyond, defining the biochemical bases for associated outcomes in fresh and processed products. Value-added benefits resulted from implementation of electrical stimulation, boxed beef and modified-atmosphere packaging, restructuring technologies, collagen recovery, and muscle profiling work. Isolation, purification, and definition of the primary structure and biophysical properties of the myofribillar and cytoskeletal proteins in muscle aided the understanding of contraction and postmortem changes. The role of Ca-dependent proteases in meat tenderness and muscle growth is being clarified. The chemistry of meat curing, meat emulsion formation, fermentation, and other processing methods led to new technologies, new meat products, and new benchmarks in product shelf life and quality. Meat safety assurance and our ability to manage the microbiological causes of food-borne illness and spoilage are imminently important now and in the future.

Effects of birth weight and postnatal nutrition on neonatal sheep: III. Regulation of energy metabolism.

This study investigated effects of birth weight and postnatal nutrition on regulation of energy metabolism in the neonatal lamb. Low (mean +/- SD 2.289 +/- 0.341 kg, n = 28) and high (4.840 +/- 0.446 kg, n = 20) birth weight male Suffolk x (Finnsheep x Dorset) lambs were individually reared on a liquid diet to grow rapidly (ad libitum fed, ADG = 337 g, n = 20) or slowly (ADG = 150 g, n = 20) from birth to live weights (LW) up to approximately 20 kg. At birth, small newborns had higher plasma concentrations of urea nitrogen (mean +/- SEM 8.31 +/- 0.25 vs 6.39 +/- 0.32 mM, P = 0.002) and somatotropin (ST, 49.1 +/- 17.0 vs 10.8 +/- 4.3 ng/mL, P = .045) and lower IGF-I (36.1 +/- 6.8 vs 157.7 +/- 21.8 ng/mL, P < 0.001) than large newborns. Plasma glucose (1.42 +/- 0.23 vs 2.63 +/- 0.95 mM, P = 0.147) and insulin (0.09 +/- 0.02 vs 0.13 +/- 0.06 ng/mL, P = 0.264) concentrations did not differ. Urea nitrogen concentration in plasma peaked and then declined rapidly in all lambs during the first week postpartum, and plasma ST declined on a body-weight-related basis from birth. During rearing to 20 kg LW, plasma insulin was higher in low- vs high-birth-weight lambs. Lambs fed ad libitum had greater plasma concentrations of glucose, urea nitrogen, insulin, and IGF-I compared to those fed a restricted diet (ADG = 150 g). The results suggest that during the early postpartum period, newborn lambs exhibit the fetal characteristic of high rates of amino acid oxidation. The results also support the notion that, at birth, low-birth-weight lambs are less mature than high-birth-weight lambs in aspects of metabolic and endocrine development, which may enhance their capacity to utilize amino acids for energy production and to support gluconeogenesis during the immediate postpartum period. Being small at birth also resulted in elevated plasma insulin concentrations when adequate nutriment to support moderate or rapid growth was provided postpartum, although it remains to be elucidated whether this more chronic effect persists in the longer term.

Effect of extruded full-fat soybeans on conjugated linoleic acid content of intramuscular, intermuscular, and subcutaneous fat in beef steers.

Crossbred Angus steers (n = 30) were used to determine whether the conjugated linoleic acid (CLA) content of beef fat could be increased by feeding varying levels of extruded full-fat soybeans as a source of polyunsaturated fatty acids for rumen biohydrogenation. Diets were as follows: 1) control, 2) 12.7% extruded full-fat soybeans (LESB), and 3) 25.6% extruded full-fat soybeans (HE SB). Steers were individually housed and fed the diets for 111 d during the finishing period. Over the experimental period, treatment groups were similar in ADG (1.7 +/- 0.1 kg/d) and had a similar slaughter weight (603 +/- 11.6 kg). Dressing percentage averaged 61.6% and carcass composition averaged 14.3% protein, 30.9% lipid, and 54.8% water. At slaughter, the intramuscular, intermuscular, and subcutaneous fat depots were sampled from the rib longissimus, eye of round, and chuck tender muscles. Across all fat depots, the CLA content differed (P < 0.05), averaging 6.6, 6.7, and 7.7 mg/g of fatty acids for the control, LESB, and HESB diets, respectively. There were significant differences in CLA content between fat depots within a cut, but differences were relatively small and the hierarchy in fat depots was not consistent among cuts. The cis-9, trans-11 isomer was the predominant CLA isomer and its content in fat was related to trans-11 C18:1 content (r = 0.53; P < 0.001). There was substantial individual variation in CLA content and this varied from 2.6 to 17.0 mg/g fatty acids across all treatments and fat depots. Overall, results demonstrated that including extruded full-fat soybeans in the diet of finishing steers increased the CLA content of beef fat. Differences were relatively small and the relationship of this to rumen fermentation and endogenous synthesis of CLA is considered.

Optimization of rate and efficiency of dietary nitrogen utilization through the use of animal by-products and(or) urea and their effects on nutrient digestion in Holstein steers.

The objective of this N balance study was to determine the potential for improving the efficiency and rate of dietary N utilization in Holstein steers by feeding an amino acid-balanced mixture of animal by-product protein sources in combination with urea. The Beef NRC 1996 Model Level 2 was used to formulate a corn-based (86:14 concentrate-hay) control diet with soybean meal as the primary N supplement that would provide ME and metabolizable protein (MP) allowable ADG of 1.4 kg in 250-kg steers with an estrogenic implant and fed an ionophore. A combination of porcine meat and bone meal, fish meal, hydrolyzed feather meal, and blood meal was also formulated as an undegradable intake protein (UIP) blend to complement those amino acids (AA) derived from microbial protein synthesis. Four steers with an average initial BW of 259 kg were assigned in a 4 x 4 Latin square design to treatments consisting of control, two levels of UIP inclusion (2.6 and 5.2%; DM basis) in combination with urea, and a negative control "urea diet" containing no UIP and no SBM. The steers were fed at hourly intervals 95% of ad libitum intake and were injected with 500 microg of estradiol-17beta twice daily. Nitrogen intakes were 155, 160, 162, and 145 g/d, and N balances were 47, 51, 42, and 47 g/d when the 0, 2.6, 5.2% UIP and the urea diets were fed, respectively. Nitrogen balance was reduced with the 5.2% UIP diet (P < 0.05), and was less than the capacity estimate derived from abosmasal casein infusion studies. Apparent N digestibilities averaged 69%, but DM, OM, and nonstructural carbohydrate digestibilities were significantly reduced for the urea diet. Feeding 5.2% UIP in the diet reduced (P < 0.05) the biological value from 46 to 38%, which was accompanied by a significant elevation of plasma urea N. Results indicate that genetic capacity for N retention was approximately 51 g/d. Results demonstrate that use of an AA-balanced blend of animal by-product protein sources did not improve the efficiency of dietary N usage when added to corn-based diets formulated with the Beef NRC 1996 Model Level 2 to meet nutrient requirements of rapidly growing steers. Using urea as the only N supplement achieved equal rate and efficiency of N use.

Performance and meat quality of beef steers fed corn-based or bread by-product-based diets.

A feeding trial was conducted with beef breed steers (120) to determine the effects of substituting bread by-product (BBy) for whole shelled corn on performance and meat quality. Chemical analysis of each diet ingredient and in vitro rates of digestion from gas production of BBy and corn were determined to provide accurate information for diet evaluations using the 1996 Beef NRC Model Level 2. Bread by-product contained 16% CP (75.6% degradable) and 75.1% non-structural carbohydrates (70% as starch, which had a digestion rate of 16%/h). The steers were given one estrogenic implant (Synovex-S) and started on the experiment at 15 mo of age and an average weight of 364 kg. The cattle were commercially slaughtered in three groups (40 steers at 101, 60 steers at 126, and 20 steers at 160 d on feed) weighing an average of 553 kg when they reached a small degree of marbling. Carcasses were electrically stimulated to prevent cold shortening of muscles. Warner-Bratzler shear force values were measured in rib steaks at 5, 14, and 21 d after slaughter (n = 76). Rib steaks from 30 steers per treatment were evaluated for palatability traits. Use of BBy at 55% of the diet (substituted for 75% of the corn) significantly improved feed efficiency by 8.1%. There were no statistically significant differences between the two diets for effects on ADG, carcass characteristics, shear force values, or sensory panel ratings of tenderness, juiciness, flavor, or overall acceptability. After adjusting intestinal starch digestibility in Level 2 to 63% for the whole corn and 90% for the BBy, predicted ADG matched that observed. Apparent NE(g) values for BBy and corn were 1.57 and 1.41 Mcal/kg, respectively.

Temporal change in skeletal muscle IGF-I mRNA abundance and nitrogen metabolism responses to abomasal casein infusion in steers.

Skeletal muscle IGF-I and alpha-actin mRNA responses to increased amino acid availability were investigated in young, rapidly growing steers. Four Holstein steers (208 kg BW) were surgically implanted with an abomasal cannula and jugular catheters and allowed 2 wk to recover. Steers were offered hourly a 43:57 forage:concentrate diet at 95% of ad libitum intake supplemented with continuous abomasal infusion of glucose (to replace 12.5% of metabolizable ad libitum energy intake) for 13 d before the start of abomasal infusion of 67 g of casein N/d. Biopsies of the liver and both semimembranosus muscles were removed and frozen in liquid N, and casein infusion was begun. Muscle biopsies were collected at 8, 16, 24, and 48 h, and on d 7 and 14. Nitrogen balance increased from 23.6 to 71.5 g/d (P < .001) within 24 h and remained elevated (mean = 58.4 g/d) during the 14 d of casein infusion. Plasma urea N increased from 4 to 9.5 mg/dL at 24 h and remained unchanged to d 14. Muscle IGF-I mRNA abundance increased to 215% of basal values at 16 h (P < .01), 244% of basal values at 24 h, and 222% of basal values at 48 h after initiation of casein infusion. Values reached a maximum of 274% of basal values on d 7 and then declined to near preinfusion levels on d 14. The IGF-I mRNA abundance was approximately 100 times higher in liver than in skeletal muscle and was not different on d 0 and 14. Although plasma IGF-I concentrations were numerically higher during the first 24 h of abomasal casein infusion, they were not significantly higher during the chronic phase of treatment. Plasma IGF binding protein (BP)-2 concentrations were higher at 16, 24, and 48 h after casein infusion was begun, but IGFBP-3 concentrations were not altered at these sampling times. Neither acute (first 24 h) nor chronic (daily) plasma insulin concentrations were altered by abomasal casein infusion. Plasma somatotropin concentrations were lower (P = .008) at 24 h of casein infusion and beyond. Results suggest that enhanced amino acid availability may modulate skeletal muscle protein synthesis and accretion through an autocrine or paracrine IGF-I influence.

Effects of a dietary mixture of meat and bone meal, feather meal, blood meal, and fish meal on nitrogen utilization in finishing Holstein steers.

Our objective was to determine to what extent rate and efficiency of protein gain in finishing cattle can be enhanced by feeding an amino acid-balanced mixture of undegraded intake proteins. The Cornell Net Carbohydrate and Protein System (CNCPS) model was used to formulate a corn-based diet that would meet the rumen requirements for 410-kg large-framed steers with an estrogen implant and fed an ionophore. The CNCPS model was also used to formulate a highly undegradable intake protein (UIP) mixture from meat and bone meal, blood meal, fish meal, and hydrolyzed feather meal to provide the amino acids needed to supplement those derived from microbial protein to better meet amino acid requirements for growth. Four Holstein steers weighing 407 kg were offered a 90:10 concentrate-forage diet at hourly intervals at 95% of ad libitum intake. The steers were injected with 500 microg of estradiol-17beta at 12-h intervals to mimic the effects of an estrogenic implant. Treatments planned consisted of inclusion of the UIP mixture at 0, 2.5, 5, and 7.5% of the diet DM. Dry matter intake was fixed at 6.4 kg/d, and DM digestibility was not significantly affected by varying the amount of UIP addition. Apparent digestibility of N increased (P = .011) from 63.8 to 65.8, 70.7, and 71.5%, the amount of N absorbed increased (P = .001) from 73 to 84, 100, and 106 g/d, and N balance increased (P = .003) from 20 to 30, 33, and 39 g/d when UIP was fed at 0, 2.6, 5.2, and 7.8% of diet DM, respectively. The efficiency of N use increased 39.7%, and biological value increased 31.6% when the UIP mixture was added to the diet. Circulating concentrations of plasma urea N (PUN) were increased (P = .017) from 4.5 for the control diet to 5.7, 6.2, and 6.1 mg/dL when the UIP mixture was added at 2.6, 5.2, and 7.8%, respectively. Corresponding IGF-I concentrations were also increased from 491 to 558 and 624 ng/mL with 2.6 and 5.2% levels of UIP addition. Plasma glucose, NEFA, and insulin concentrations were not affected by feeding the UIP mix. The rate and efficiency of N use for growth improved with addition of an amino acid-balanced UIP mixture to the diet.

The beta-agonist cimaterol directly enhances chronic protein accretion in skeletal muscle.

Our objective was to determine whether the chronic anabolic effects of beta-adrenergic agonists on skeletal muscle are direct and how long they are maintained. We studied acute (6 h) and chronic (1 to 20 d) effects of cimaterol (CIM) on skeletal muscle metabolism and protein accretion by use of close arterial infusion in the hindlimbs of six young steers. Surgical catheterizations were conducted to allow continuous infusion of CIM (.5 microg/min) or saline into the external iliac artery of contralateral hindlimbs and simultaneous sampling for arteriovenous difference measurements. Hindlimb blood flow and net flux of amino acids, glucose, lactate, and NEFA were determined during a basal period before infusion, at 6 h, and at 1, 3, 7, 14, and 20 d of infusion. Cimaterol infusion acutely stimulated blood flow and caused acute mobilization of nitrogen (alanine), NEFA, and lactate from the treated hindlimb. Cimaterol infusion increased net uptake of amino acids (P < .05) in treated and control hindlimbs after 1 d of CIM infusion, but a progressive increase between 1 and 14 d of infusion was observed only in the treated hindlimbs. Net uptake of total amino acids in the treated hindlimb was increased 50 and 80% (P < .05) at 7 and 14 d, respectively, when compared to the control hindlimb and was increased 260% at d 14 when compared with the basal period. Net amino acid uptake was not different between treated and control hindlimbs by d 20 of CIM infusion. Integration of net tyrosine and phenylalanine uptake over the entire infusion period predicted a 10% difference in skeletal muscle protein mass between treated and control hindlimbs. Semitendinosus and semimembranosus muscles in the treated hindlimb contained 9 and 11% greater protein content, respectively (P < .05), at the end of the infusion period. Results provide a quantitative description of the temporal pattern of transient effects of CIM on skeletal muscle metabolism and protein accretion and provide evidence that these are direct effects.

Nutrition, development and efficacy of growth modifiers in livestock species.

Somatotropin (ST) and synthetic beta-adrenergic agonists (beta-AA) are growth-modifying agents that increase the rate and sometimes, the efficiency of protein deposition in lean tissues of livestock species. The ST-induced increase in muscle protein deposition is effected by a relatively modest increase in protein synthetic rate. This is possibly mediated by the endocrine influence of marked increases in circulating IGF (insulin-like growth factor)-I, and other ST-dependent components of the IGF system; mediation by locally expressed IGF-I may also occur. Increased muscle protein accretion in animals treated with beta-AA seems to be directly mediated by binding of the synthetic agonist to muscle beta-1 or beta-2 receptors, leading to increased muscle protein synthesis, possibly accompanied or followed by decreased protein degradation. This response is transient, due to down-regulation of beta-adrenergic receptors. Maximal responses of muscle protein accretion to both ST and beta-AA are attenuated by feeding inadequate levels of total protein or specific, limiting amino acids. For ST, but not beta-AA, this effect in growing pigs is partially offset by increased efficiency of utilization of absorbed amino acids for protein deposition, with predictable consequences for dietary protein and amino acid requirements. Both ST and beta-AA are less efficacious in promoting muscle protein deposition in very young animals. For ST, this is related to postnatal development of the somatotropic axis; a mechanistic explanation for the similar lack of effect of beta-AA is lacking. In both cases, this phenomenon must be considered against the very high inherent capacity and efficiency of lean tissue protein accretion in the neonate.

Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.

The consequences of a 42 d exposure to elevated growth hormone (GH) on adipose tissue were assessed using the regulatable ovine metallothionein- ovine GH (oMt1a-oGH) transgene in male and female GH transgenic (TG) mice. Activation of transgene expression at 21 d of age followed by inactivation of transgene expression at 63 d of age (TG-on/off) increased individual white adipose tissue (WAT) depots and total body lipid stores in both males and females. WAT, expressed as a percentage of fasted body weight, did not differ in wildtype (WT) and continuously activated TG males and females up to 105 d of age, but was increased approximately 270% following inactivation of the transgene. Inguinal depot adipocytes were more numerous in both male and female TG +/- relative to WT or TG animals. The ensuring obesity was not accompanied by a decrease in thermogenic capacity of brown adipose tissue, as indexed by uncoupling protein quantity. GH transgene expression was accompanied by elevated insulin levels that were restored to WT levels upon cessation of transgene expression (p > 0.1). Early, transient exposure to elevated GH increased total body lipid by nearly threefold independent of gender; the increased lipid content was sustained and reflected WAT hypertrophy and hyperplasia. The oMt1a-oGH mouse provides a novel model of induced obesity in response to inactivation of a GH-transgene by the withdrawal of the transgene stimulus.

Characterization of dose-dependent metabolic responses to close arterial infusion of cimaterol in the hindlimb of steers.

Dose-dependent effects of cimaterol (CIM) on hindlimb metabolism were determined in six steers (247 +/- 22 kg BW) using a close arterial infusion. The external iliac vessels of both hindlimbs were catheterized to accommodate measurement of blood flow, circulating concentrations, and net flux of NEFA, lactate, and alpha-amino nitrogen (AAN) during infusion of CIM at 0, .05, .1, .3, .7, 1 and 3 micrograms/ min. Close arterial infusion of CIM in the hindlimb of steers can be used to achieve a local concentration elevation that is required to differentiate local and systemic effects in vivo. Calculated plasma threshold CIM concentration required to initiate cardiovascular responses was 21 pg/mL, which resulted from an infusion rate of .3 microgram/min. Threshold concentrations of CIM for stimulation of NEFA and lactate net flux in the hindlimb were 38 and 34 pg/mL, respectively, and would be achieved with an infusion rate of .7 microgram/min. All measured responses except AAN net flux exhibited significant linear and quadratic dose effects, and responses in the treated hindlimb were always severalfold greater than in the contralateral control hindlimb. Maximal differences between treated and control hindlimb blood flow occurred with a CIM infusion rate of .7 microgram/min, but the highest infusion rate (3 micrograms/min) was required to maximize differences in NEFA and lactate flux. Therefore, to minimize cardiovascular and other systemic responses and optimize direct hindlimb responses, an infusion rate of .5 microgram of CIM/ min should cause significant stimulation of beta-adrenergic receptors only in the CIM-infused hindlimb of young, growing steers.

Impact of composition manipulation on lean lamb production in the United States.

At present less than 30% of the market lambs slaughtered in the United States meet the requirements for leanness and muscling as specified in the "Certified Fresh American Lamb" program established in 1990 by the American Sheep Industry Association (ASI). Carcass composition of slaughter lambs is determined by stage of growth relative to mature size, genotype, sex, and matching dietary nutriment to nutrient requirements for lean tissue growth. On the average, current production strategies produce carcasses that contain excessive amounts of fat, impeding optimized efficiency at all levels of production. Use of large-mature-size terminal sires, feeding rumen-escape dietary protein, feeding intact males, and slaughtering at appropriate weights all improve composition of gain. Improvements of 10 to 20% in rates of gain and efficiency of nutrient use and similar reductions in feed cost can be achieved with each of these management strategies. Results from several experiments demonstrate that these effects are additive and provide a measure of the true genetic capacity for protein accretion rate in growing lambs. Adoption of these management strategies will allow lambs to be slaughtered at a younger age, which may improve meat quality and concurrently reduce the amount of nitrogen waste returned to the environment. Potential for further manipulation of composition exists through more accurately defining nutrient requirements of growing lambs and through use of metabolism modifiers. Maintaining a competitive, profitable, and sustainable sheep industry depends on continued improvement of production efficiency, preferably in systems with high reproductive rates.

Effects of exogenous somatotropin on whole-body glycemic response to insulin in young preruminant and ruminant lambs.

The purpose of this study was to determine the effects of exogenous recombinant bovine somatotropin (bST) treatment on whole-body glycemic responsiveness and sensitivity to exogenous insulin in preruminant and ruminant lambs. Twelve milk-fed (MF) and 12 ruminating (RUM) wether lambs weighing 20 +/- 0.6 kg were assigned to one of four treatment groups: MF control, MF plus bST, RUM control, and RUM plus bST. Lambs received a daily subcutaneous injection of 160 micrograms of sometribove (recombinant methionyl bST) bST/kg live weight or the equivalent volume of sterile water (control) for 10 d. The MF lambs had higher plasma insulin and nonessential fatty acids and lower acetate concentrations than RUM lambs (all P < 0.05). Plasma insulin-like growth factor concentrations were similar in both. The administration of bST raised plasma insulin-like growth factor-1 (P < 0.001) and insulin (P < 0.05) in MF and RUM lambs, but with greater effect in MF lambs (P < 0.01 and P < 0.1, respectively). Six successive dose-incremented insulin challenges (50, 100, 200, 300, 500, and 700 mU/kg body weight) were performed two per day on Days 8, 9, and 10 of treatment. Dose-response curves for absolute decline in glucose concentration from preinjection baseline to nadir were used to characterize whole-body responsiveness and sensitivity (ED50) to insulin. Somatotropin treatment increased insulin ED50 values 64 and 70% (P < 0.07) in RUM and MF lambs, respectively, suggesting that sensitivity to insulin was reduced. Insulin ED50 values were 40% higher in MF than in RUM lambs (P < 0.05). Insulin clearance rates increased with each dose increment to 300 mU/kg body weight (P = 0.001) and were 50% lower in bST-treated MF lambs than in all other treatment groups (P < 0.05). Results suggest that somatotropin modulates the insulin control of glucose homeostasis similarly in preruminant and ruminant lambs by decreasing sensitivity but not maximum responsiveness.

Porcine somatotropin affects the dietary lysine requirement and net lysine utilization for growing pigs.

This study was conducted to determine the effects of exogenous porcine somatotropin (pST) on the dietary lysine requirement and efficiency of absorbed lysine utilization for pigs during the 20- to 60-kg phase of growth. Seventy-two crossbred pigs (20 +/- 0.7 kg body wt) received daily intramuscular injections of either excipient (0 dose) or pST (150 micrograms/kg body wt) and were fed diets in which protein and lysine concentrations ranged from 6.4 to 23.5 g/100 g diet and from 0.40 to 1.48 g/100 g diet, respectively. Nutrient density was altered to compensate for reduced feed intake with pST, but diets were approximately isocaloric. Rate and efficiency of gain and whole-body protein accretion rate exhibited a dose-response improvement (P < 0.01) to increases in dietary protein for both excipient and pST-treated pigs. Pigs receiving pST grew more rapidly and more efficiently than control counterparts (P < 0.01). Treatment with pST improved the rate of protein accretion (P < 0.01) at all but the lowest level of dietary protein. The net lysine utilization for lysine accretion and maintenance was 0.46 for control pigs and 0.57 for pigs receiving pST, a 24% improvement in the efficiency. Thus, treatment with pST increased the maximum rate of protein accretion as well as the partial efficiency with which dietary lysine is used for protein accretion. Consequently, only a 9% increase in dietary lysine was required to maximize protein deposition in pST-treated pigs, because the metabolic efficiency of lysine utilization was improved.

Dose-dependent effects of exogenous porcine somatotropin on the yield, distribution, and proximate composition of carcass tissues in growing pigs.

Dose-dependent effects of porcine somatotropin (pST) on mass, distribution, and proximate composition of carcass tissues were investigated in 46 growing pigs. Barrows, weighing 30 +/- 1 kg, were assigned to five treatment groups to receive 0, 50, 100, 150, or 200 micrograms of recombinant pST/kg BW per day until pigs individually reached the 90-kg slaughter weight. Left carcass sides were fabricated into whole-sale cuts that were separated into muscle, adipose tissue, bone, and skin. Despite the reduction in dressing percentage, total muscle mass of the side was significantly increased by 3.9 to 5.7 kg (28 to 36%) by the lowest and highest doses of pST, respectively, whereas adipose tissue mass was decreased by 4.4 to 8.6 kg (38 to 74%). Bone mass was increased by 8 to 27% (P < .05), and skin mass was increased by 16 to 38% (P < .01) across the dose range. Distribution of carcass weight among the wholesale cuts was altered by pST toward lower proportions in the belly, jowl, and fat trimmings and greater proportions in the four lean cuts. Porcine somatotropin substantially reduced lipid concentration in all muscle groups in a dose-dependent manner, resulting in increased protein and moisture concentrations (P < .05). Adipose tissue lipid concentrations were reduced to an even greater extent at each dose. The progressive increase in muscle mass observed with pST doses > 50 micrograms/kg BW was less than the associated decrease in adipose tissue mass, indicating that a dose range of 50 to 100 micrograms/kg BW per day may be optimum for improving carcass value.

Analysis and pharmacokinetics of cimaterol in growing Holstein steers.

Pharmacokinetic parameters for the beta 2-adrenergic agonist, cimaterol (CIM), were determined in growing Holstein steers. Compartmental analysis was used after measurement of CIM in body fluids by affinity chromatography and HPLC using UV detection. Recoveries from spiked plasma and urine standards were 70 +/- 1.2% and 68 +/- 1.1%, respectively. The minimum detection level in plasma was 1 ng/mL and the average CV was 5.1% for concentrations that ranged from 1 to 30 ng/mL. Four steers (276 +/- 24 kg) received 15 mg of CIM by bolus intravenous injection. Plasma CIM levels declined in a biphasic manner with half-lives of 2.5 min for the distribution phase and 54 min for the elimination phase. A two-compartment open model was used to describe the disappearance of CIM and the following pharmacokinetic parameters were obtained: central compartment volume (Vc) = .76 L/kg, apparent volume of distribution (Vd) = 4.1 L/kg, and transfer rate constants from the central to peripheral compartment (k12) = .177/min, from the peripheral to central compartment (k21) = .054/min and elimination from the central compartment (kel) = .074/min. After 8 h, total urinary CIM accounted for only 18.3% of the administered dose. Results suggest that circulating concentrations of CIM in growing steers are influenced by its accumulation in an unidentified peripheral pool and its conversion into unknown metabolite(s) before elimination.

Influence of genotype and sex on the response of growing pigs to recombinant porcine somatotropin.

The dose-dependent effects of porcine somatotropin (pST) on growth performance and composition of carcass gain were investigated in 150 growing pigs. The experiment involved two genotypes (barrows from the Pig Improvement Company [PIC] and a University of Nebraska [NEB] gene pool line) and two sexes (PIC barrows and boars). At 30 kg, pigs were randomly assigned within each genotype and sex subclass to receive daily i.m. injections of 50, 100, 150, or 200 micrograms of pST/kg BW or an equivalent volume of an excipient. A diet (3.5 Mcal of DE/kg) supplemented with crystalline amino acids and containing 22.5% CP was available on an ad libitum basis until pigs were slaughtered at approximately 90 kg live weight. Excipient-treated PIC barrows exhibited faster and more efficient growth (P less than .001) and a higher capacity for carcass protein accretion (P less than .001) but similar rates of lipid deposition compared to excipient-treated NEB barrows. Within the PIC genotype, control boars grew at a rate similar to that of barrows, but they were more efficient (P less than .05) and deposited more carcass protein (P less than .05) and less lipid (P less than .001). Carcass protein accretion rate increased (P less than .001) up to approximately 150 micrograms of pST.kg BW-1.d-1, whereas lipid deposition decreased (P less than .001) with each incremental dose of pST. Although differences between PIC boars and barrows for all criteria were negated with increasing pST dose, they were maintained between the two genotypes. Polynomial regressions suggested that a slightly higher pST dose was required to optimize the feed:gain ratio compared with rate of gain and that the dose (micrograms per kilogram BW per day) was a function of the genotype and sex (feed:gain: 185, 170, and 155; rate of gain: 155, 155, and 125 for NEB barrows, PIC barrows, and PIC boars, respectively).

Dynamic and static phases of severe dietary obesity in sheep: food intakes, endocrinology and carcass and organ chemical composition.

The chronology of changes in body weights, food intakes and plasma concentrations of selected metabolic hormones and metabolites were determined in sheep during the induction (dynamic) and static phases of diet-induced obesity. Lean adult Dorset ewes weighing 47 kg were fed a pelleted hay-grain diet at maintenance (lean; n = 7) or were fed the same diet ad libitum to a maximum intake of 3 kg.sheep-1.d-1 (obese; n = 8) for 78 wk. Body weight of obese sheep doubled (97 vs. 47 kg) by wk 42 of ad libitum intake. Average daily intakes of dry matter (12.8 g/kg) and digestible energy (165 kJ/kg) were comparable in maintenance-fed lean sheep and ad libitum-fed obese sheep consuming maintenance after wk 50, which began the static phase of obesity. Fasting plasma concentrations of insulin in the obese sheep increased steadily from 50 +/- 6 pmol/L at wk 0 to a sustained plateau of 249 +/- 21 pmol/L after wk 30. Plasma levels of glucose, immunoreactive glucagon and thyroid hormones were consistently greater (P less than 0.05) in obese sheep than in lean sheep after wk 2, 3 and 25, respectively, of the experiment. Concentration of lipid (49 vs. 25%) in the carcass stripped of internal fat was greater (P less than 0.01) in obese sheep than in lean sheep, but concentration of protein (10.4 vs. 15.3%) was less in the heavier carcass (58 vs. 24 kg) of the obese sheep. We conclude that hyperinsulinemia and abnormal fuel metabolism are early events during dynamic obesity and these defects persist throughout the static phase of obesity. Maintenance energy requirements relative to unit body weight (W1.0) seem similar in lean and dietary obese sheep.

Effect of an implant of trenbolone acetate and estradiol on growth, feed efficiency, and carcass composition of Holstein and beef steers.

The effects of an implant of 140 mg of trenbolone acetate and 28 mg of estradiol (TBA + E2) on performance and carcass composition were evaluated with 72 individually fed steers. Holstein (n = 24), Angus (n = 24), and Angus x Simmental (n = 24) steer calves were allocated by breed and implant treatment to either an individual feeding pen (n = 36) or an electronic feeding door in a group pen (three pens with 12 animals per pen). Intake and refusal of the 85% concentrate diet were recorded daily. Animals were slaughtered when ultrasonic attenuation values of the longissimus muscle at the 12th rib reached .55, which is correlated with low Choice marbling. At slaughter, complete carcass measurements were taken and the right side of each carcass was separated into boneless wholesale cuts. Implanting with TBA + E2 improved (P less than .01) daily gain and feed efficiency. Daily gain was increased 17, 26, and 21% in Holstein, Angus, and crossbred steers, respectively. The implant increased overall daily protein and fat accretion 23%. Carcass conformation and dressing percentage were not affected (P greater than .05) by TBA + E2 treatment. Implantation with TBA + E2 had little effect on yield of wholesale boneless cuts when expressed as a percentage of carcass weight but increased absolute weight as a small degree of marbling by 6 to 40 kg.